Global Point of Care (POC) Diagnostics Market to Witness Sustainable Growth: In-depth Industry Analysis with Key Player’s Strategic Movement; Danaher, Roche, Alere, bioMerieux, Abbott, and Siemens

AnalystView Market Insights has announced the addition of the “Global Point of Care (POC) Diagnostics Market Industry Analysis and Opportunity Assessment 2014 – 2025” market research report. The global point of care (PoC) diagnostics market is expected to grow at growth rate of 7.1% to reach USD 21.8 billion by 2025. The report analyzes the industry in terms of the product, disease condition, and geography. This comprehensive study reveals the market estimate numbers for different market segments. Key industry dynamics, regulatory scenario, and strategic benchmarking and thorough competitive landscaping are discussed, spreading over 150 pages.

Point of care testing is rapidly growing diagnostic technique to produce quality laboratory results in short time period. These molecular tests are simple to use, fast, portable and inexpensive. Due to these benefits, a point of care testing is increasingly used by end-users to test cholesterol and glucose levels, test for drugs of abuse, enzyme analysis, for pregnancy testing and various other reasons. Increasing incidence of target diseases is anticipated to stimulate the uptake of a point of care testing, driving the market growth. For instance, annually, large number of population dies due to cardiovascular disease. According to estimates from the World Health Organization (WHO), around 17.7 million people died from the cardiovascular disorders in 2015 which is projected to reach 23.3 million deaths by 2030. Such facts will boost the utilization of these tests, hence support the market growth. However, regulatory issues will pull back the market growth to some extent.

To request a free sample copy:
https://www.analystviewmarketinsights.com/request_sample/av203/

Key Takeaways
- Growing prevalence of target diseases such as diabetes, cancer, cardiovascular diseases and infectious diseases is projected to serve this market as a high impact rendering driver
- Government contracts primarily contributing towards the development of point of care diagnostics equipment in European countries
- Blood glucose point of care testing accounted for the largest share of the market owing to the rising diabetes incidences coupled with sheer volume of these tests marketed and currently under usage
- Hospitals recorded the highest revenue in 2017, expanding at 3.3% growth rate in future due to the rising adoption of point of care diagnostic testing
- The U.S. captured the largest share of the global market. The growth of this country is majorly attributed to the rise in demand for POC testing and increasing prevalence of target disease.
- Tough competition among leading market players. Roche Diagnostics, Abbott Laboratories, Danaher Corporation, and Siemens is considered to be the most dominating participants of the market owing to the extensive product portfolio and aggressive business strategies

Browse full report with in-depth TOC on “Point of Care (POC) Diagnostics Market, By Product, By Disease Condition and Geography - Analysis, Share, Trends, Size, & Forecast from 2014 – 2025” at
https://www.analystviewmarketinsights.com/report-highlight-point-of-care-poc-diagnostics-market/

The scope of the Report:

The market, by Product:
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Urinalysis
- Fertility
- Cardiac Markers
- Infectious Diseases
- Hematology
- Decentralized Clinical Chemistry
- Ambulatory Chemistry
- Drug Abuse Testing
- Others

The market, by Disease Condition:
- Human Immunodeficiency Virus (HIV)
- Respiratory Syncytial
- Human papillomavirus (HPV)
- Clostridium difficile
- Hepatitis B
- Pneumonia
- Influenza
- Hepatitis C
- Tuberculosis
- Others

The market, by Region: North America, Europe, Asia Pacific, Latin America, Middle East and Africa and Rest of the World

The market, by Country: U.S., Canada, Germany, France, India, and China;

Key players profiled in this report with special attention on competitive landscape includes, (can be further customized to include an additional 10 profiles of companies):
- Danaher Corporation
- Roche Diagnostics
- Alere Inc.
- bioMerieux
- Abbott Laboratories
- Siemens Healthcare

Our Value Proposition:
- The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
- A thorough analysis of relevant statistical data to estimate the market paradigms
- Exceptional understanding of the region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentations, and growth specific to the countries.
- Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

Research Methodology:
- Preliminary Data Mining: Secondary Research, Paid Databases, Primary Research
- Data Synthesis & Analysis: Top-Down Approach, Bottom-Up Approach, Supply Side and Demand Side
- Market Formulation: Market Dynamics, Total Addressable Market and Machine Learning Technique
- Data Verification: Quality Assurance and Reach a Conclusion

About Us
AnalystView Market Insights is a market research and consulting firm that adopts a proactive approach to provide the diverse need for accurate and precise market research, custom research, and consulting solutions across geographies and industry verticals. We strive to develop meaningful and evidence-based research data that helps our clients, empowering organizations and brands of all sizes with strategic analysis, accurate data, and consumer trends for various industries such as Healthcare, Bulk Chemicals, Semiconductors, Electronics, and Foods and Beverages.

Contact Us
Mr. Jose (Press & Marketing Manager)
Corporate Sales, USA
AnalystView Market Insights
Email: sales@analystviewmarketinsights.com
Tel: +91-757-498-5725 (Asia-Pacific Business Centre)
Web: www.analystviewmarketinsights.com

This release was published on openPR.